Funding Alert Vol. 24 No. 6 Alert # 2 - June 11, 2013

Loading...

Texas Department of State Health Services icon Funding Information Center icon Toll free: 1-888-963-7111 ext. 7684 icon Austin phone: (512) 776-7684 icon Fax: (512) 776-7683


The Texas Department of State Health Services Funding Alert is published weekly.  If you wish to subscribe to the Funding Information Center Funding Alert and other services, please call (512) 776-7684 or fill out our online subscription form which can be found at: https://www.dshs.state.tx.us/fic/subscribe.aspx.  Information in the Funding Alert is not copyrighted and may be reproduced. The Texas Department of State Health Services Funding Information Center would appreciate credit for the material used and a copy of the reprint. For information on viewing Adobe Acrobat .pdf and other files, see file viewing information.

Disclaimer: External links to other sites are intended to be informational and do not have the endorsement of the Department of State Health Services. These sites may also not be accessible to persons with disabilities. External e-mail links are provided to you as a courtesy. Please be advised that you are not e-mailing the Texas Department of State Health Services (DSHS) and DSHS policies do not apply should you choose to correspond.


Funding News and Grant Tips

Foundation Transparency: What Nonprofits Want
In a report released by the Center for Effective Philanthropy (CEP), nonprofit organizations call for greater transparency from the foundations that fund them. What’s more, they have very specific views about what transparency means and why it matters.
Foundation Transparency: What Nonprofits Want, by CEP’s Andrea Brock, Ellie Buteau, and Ramya Gopal, is based on a survey of 138 nonprofit leaders, representing organizations large and small (one staff to 1,300 staff), young and old (5 to 160 years-old), from around the nation. The survey sample is representative of nonprofits that receive support from large foundations.
“When we analyzed all the data, some clear points emerged,” said Vice President-Research Ellie Buteau.
“Overwhelmingly, the leaders of these nonprofits say they want foundations to be more transparent about what foundations are learning through their work,” said Buteau. “Nonprofit leaders also want foundations to be more transparent about how they assess performance and impact of both the grantees they fund and the foundations themselves. Finally, nonprofit leaders want more transparency about processes for selecting nonprofits and changes that affect the funding that grantees will receive,” she said.
“The survey data is sobering,” said CEP President Phil Buchanan. “There’s a lot of well-intentioned talk about the importance of sharing information, and that’s a good start. But it’s time to be serious about what we mean by ‘transparency.’ Foundations that share staff contact information or post their Form 990 on their website can congratulate themselves for being transparent. Nonprofits know better. Our survey clearly shows that for a nonprofit leader, foundation transparency means being clear, open, and honest about the processes and decisions that are relevant to nonprofits’ work,” he said.
According to Buteau, only 29 percent of nonprofit leaders report having a clear understanding of how foundations use the information the nonprofit is required to provide. Forty-four percent of nonprofit leaders are unclear about how their work fits into their funders’ overall work. Fifty-one percent of the nonprofit leaders surveyed want “a lot more” transparency about what foundations are learning. And more than 75 percent say they want more transparency about the impact that foundations themselves are having.
“It’s clear that foundations have a lot of work to do when it comes to their communications with grantees,” said Buchanan. “But the good news is that there’s an important payoff for foundations who deliver the sort of transparency that helps grantees. The data shows that foundations that are more transparent are perceived to be more helpful to nonprofits, easier to develop good relationships with, and more credible. That’s the basis of a great relationship with the folks who use your foundation’s resources to carry out your mission,” he noted.
Buchanan noted that transparency is an achievable goal for any foundation.
The report is a result of CEP’s The Grantee Voice: a panel of 300 nonprofit leaders from across the country who have agreed to share their experiences working with foundation funders.
“Through research like this, CEP intends to provide an overview of nonprofits’ experiences and perspectives. We aim to contribute data, as well as new questions, to further important conversations about how foundations and grantees can work most productively together,” said Buteau.
From Texas Non Profits, 6/4/13icon

Robert Wood Johnson Foundation Offers Hospital Price Data Challenge
The Robert Wood Johnson Foundation (RWJF) Hospital Price Data Challenge is designed to increase understanding and use of this recently released hospital price data. The challenge seeks entries from developers that fit into one of two categories. The visualization category encourages submissions that allow users to better understand aspects of the data such as the regional patterns or variation by procedures. These submissions may include simple tools that allow users to visualize the data in different ways. The applications/tools challenge encourages submissions that provide an analytical capacity, potentially by combining the price data with other sources of information.
For both categories, the fundamental goal is to help users better understand and potentially use hospital charge data. As appropriate, participants should incorporate other sources of data (i.e. demographic, quality, economic) to put hospital price data in context and to increase the possibility that users can leverage the data for decision-making purposes.
Category A – Visualization Challenge: The entrant provides effective data visualizations that help the public understand, explore and interpret the price data.
Submissions will help the public, organizations or communities better understand the variance and geographic patterns revealed in the hospital data, and the potential relationship to other issues including but not limited to:
* Hospital quality and patient satisfaction.
* Other characteristics of hospitals.
* Characteristics of communities and markets.
The data visualizations will tell a compelling story based on sound analysis of the inpatient and/or outpatient price data, and potentially the integration of other data sources. Visualizations can be static or interactive. Entrants must submit a web link to their submission with a video pitch and a brief text description.
For the Visualization challenge teams are required to submit a web link to the visualization submission (hosted publicly), a video pitch (no more than 3 minutes) describing the visualization(s), and a brief text description.
Final entries for the Visualization Challenge will be submitted via the Visualizing.org platform.
Category B – Apps and Tools Challenge: The entrant creates a tool or app that allows users to analyze and potentially leverage the data for purchasing decisions or to negotiate hospital bills.
Successful entrants will use either the inpatient or outpatient data, potentially in combination with other sources, to create apps or tools that will allow users such as employers, payers, and consumers to better understand these data. The tool or app would provide an analytical capacity that would increase the ability to leverage these data to improve health care decision-making or otherwise foster efficiency.
The Apps and Tools Challenge (category B) is split into two phases:
In Phase I, teams are asked to develop concepts describing the applications they would build for the second phase of the challenge. Teams must submit a brief description, wireframes, and a 10-slide PowerPoint deck. Five finalists will be selected to participate in Phase II of the challenge.
In Phase II, the top five teams that participated in Phase I are asked to create working apps and tools that build on what was proposed in Phase I. The deliverable for this phase is a 10-slide summary deck, brief description, link to working app, and a 5-minute video demonstrating the application in action.
Final entries for the Apps and Tools Challenge will be submitted via the Health 2.0 platform.
Applicants are allowed to submit into both categories of the challenge.
For more information see http://www.health2con.com/devchallenge/rwjf-hospital-price-transparency-challenge/
From RWJF e-mail, 6/6/13icon


Public Funding Opportunities

FY14 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1): RFA-DA-14-008
SOURCE: National Institute on Drug Abuse (NIDA)
APPLICATION DEADLINE: 11/6/13 by 5 pm local time of applicant organization.
$ AVAILABLE: NIDA intends to commit $2 million in FY 2014 to fund two to three awards.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. The term “avant-garde” is used to describe highly innovative approaches that have the potential to be transformative. The proposed research should reflect approaches and ideas that are substantially different from those already being pursued by the investigator or others. In keeping with the priorities described in the FY14 Trans-NIH Research Budget Justification, the NIDA Avant-Garde award supports innovative, basic research that may lead to improved preventive interventions or therapies; creative, new strategies to prevent disease transmission; novel approaches to improve disease outcomes, and creative approaches to eradicating HIV or improving the lives of those living with HIV.
CFDA: 93.279
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-14-008.html
From CDC National Prevention Information Network's (NPIN) HIV/Hepatitis/STD/TB Funding Information e-mail, 6/3/13icon
Subject(s) HIV/AIDS research, HIV/AIDS services

In-vivo Methods for Assessing Placental Development and Function (R41/R42): RFA-HD-14-004
SOURCE: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICATION DEADLINE: Letter of Intent: 7/21/13. Application: 8/21/13 by 5 pm local time of applicant organization.
$ AVAILABLE: The NIH intends to commit an estimated total of $2 million between this FOA and the companion SBIR FOA (RFA-HD-14-005) in the first fiscal year (2014).
ELIGIBILITY: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.
PURPOSE: The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating Institutes invite grant applications for research on the development of safe, real-time, non-invasive (or minimally invasive), in vivo methods to assess the development and function of the human placenta.
CFDA: 93.865, 93.286
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-14-004.html
From NIH Web site, access 6/5/13icon
Subject(s) medical research

In-vivo Methods for Assessing Placental Development and Function (SBIR) (R43/R44): RFA-HD-14-005
SOURCE: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICATION DEADLINE: Letter of Intent: 7/21/13. Application: 8/21/13 by 5 pm local time of applicant organization.
$ AVAILABLE: The NIH intends to commit an estimated total of $2 million between this FOA and the companion STTR FOA (RFA-HD-14-004) in the first fiscal year (2014).
ELIGIBILITY: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.
PURPOSE: The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating Institutes invite grant applications for research on the development of safe, real-time, non-invasive (or minimally invasive), in vivo methods to assess the development and function of the human placenta.
CFDA: 93.865, 93.286
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-14-005.html
From NIH Web site, access 6/5/13icon
Subject(s) medical research

Minority AIDS Initiative (MAI) Program Using New Media to Prevent Substance Abuse & HIV/AIDS for Populations at High Risk: SP-13-008
SOURCE: Substance Abuse and Mental Health Services Administration (SAMHSA)
APPLICATION DEADLINE: 7/2/13.
$ AVAILABLE: $2.5 million for up to 20 awards.
ELIGIBILITY: Please see URL for eligibility information.
PURPOSE: The Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention is accepting applications for fiscal year (FY) 2013 grants for Using New Media to Prevent Substance Abuse & HIV/AIDS for Populations at High Risk (Short Title: SA & HIV/AIDS Prevention & New Media). The purpose of this Minority AIDS Initiative (MAI) program is to use new media to promote targeted SA and HIV prevention messages to racial/ethnic populations at high risk for SA and HIV infection.
CFDA: 93.243
CONTACT: Please see URL for multiple contacts. For more information see http://www.samhsa.gov/grants/2013/sp-13-008.aspx
From CDC National Prevention Information Network's (NPIN) HIV/Hepatitis/STD/TB Funding Information e-mail, 6/3/13icon
Subject(s) HIV/AIDS education/prevention, minority health, substance abuse education/prevention


Private Funding Opportunities

Association for Frontal Temporal Degeneration Seeks Letters of Intent for Research Projects
SOURCE: Association for Frontal Temporal Degeneration
APPLICATION DEADLINE: Letter of Intent: 8/22/13.
$ AVAILABLE: One-year grants of up to $150,000.
ELIGIBILITY: To be eligible, applicants must be a nonprofit academic institution or for-profit biotechnology company, either public or private, anywhere in the world.
PURPOSE: The Association for Frontal Temporal Degeneration is accepting Letters of Intent from research projects that address the pathologic mechanisms of neurodegeneration in frontotemporal dementia and related disorders.
Grants will be awarded to support the development of biomarkers to accelerate drug development and early diagnosis, innovative pilot clinical trials, target validation studies, development and testing of novel high throughput screening assays, medicinal chemistry on lead compounds, identification, and in vitro testing of potentially disease modifying lead compounds. In addition, grants will support ADME, toxicology, pharmacokinetics, pharmacodynamics on lead compounds, and testing of lead compounds in a relevant animal model for preclinical proof of concept. Awards will not support applications for basic research.
CONTACT: Diana Shineman, (212) 901-8007, e-mail: dshineman@alzdiscovery.org. For more information see http://www.theaftd.org/wp-content/uploads/2009/03/2013-ADDF-AFTD-FTD-RFP.pdf
From The Foundation Center's Philanthropy News Digest RFP Bulletin e-mail, 5/31/13icon
Subject(s) medical research

Brain Research Foundation Seeks Letters of Intent for Innovative Neuroscience Research
SOURCE: Brain Research Foundation (BRF)
APPLICATION DEADLINE: Letter of Intent: 7/1/13.
$ AVAILABLE: Grants of up to $150,000 over two years.
ELIGIBILITY: To be eligible, investigators must be a full-time professor or associate professor at an institution in the United States and be working in the area of brain function and development or specific disease states.
PURPOSE: The Brain Research Foundation is accepting Letters of Intent from investigators for creative, exploratory, cutting-edge neuroscience research projects.
Through its Scientific Innovations Award program, the foundation will award grants to support projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood of producing important findings. Projects should be related to either normal human brain development or specifically identified disease states, including molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral, and emotional functioning in health and disease.
CONTACT: You may contact the BRF by email at info@thebrf.org or call (312) 759-5150. For more information see http://thebrf.org/Grants/Scientific+Innovations+Award
From The Foundation Center's Philanthropy News Digest RFP Bulletin e-mail, 5/31/13icon
Subject(s) medical research, mental health

International Association for Dental Research Accepting Applications for Caries Prevention Research
SOURCE: International Association for Dental Research
APPLICATION DEADLINE: 12/9/13.
$ AVAILABLE: Depending on the proposals and peer-review, either a single award of $75,000 or multiple smaller awards not exceeding a total of $75,000 will be offered.
ELIGIBILITY: To be eligible, the principal investigator listed in the application must be a current member of IADR and affiliated with a nonprofit academic institution.
PURPOSE: The International Association for Dental Research is accepting applications for the IADR Colgate Community-Based Research Award for Caries Prevention.
Grants will be awarded to investigators working to advance research in the field of cariology and promote oral health improvement globally, with a focus on community-based research for the prevention and management of caries.
CONTACT: Sheri S. Herren at sherren@iadr.org. For more information see http://www.iadr.com/i4a/pages/index.cfm?pageid=3905
From The Foundation Center's Philanthropy News Digest RFP Bulletin e-mail, 5/31/13icon
Subject(s) dental health, medical research

Michael J. Fox Foundation Invites Proposals for Innovative, High-Risk/Reward Research Projects
SOURCE: Michael J. Fox Foundation
APPLICATION DEADLINE: Open.
$ AVAILABLE: One-year grants of up to $75,000.
ELIGIBILITY: Eligible applicants include biotechnology/pharmaceutical companies, other for-profit entities, public and private nonprofit universities, colleges, hospitals, laboratories, and government agencies.
PURPOSE: The Michael J. Fox Foundation for Parkinson's Research is accepting applications from innovative, high-risk, high-reward projects that address critical scientific and therapeutic roadblocks which, if successful, will open new avenues for Parkinson's disease therapy development.
Through its Rapid Response Innovation Awards program, MJFF will award grants for any PD-relevant area of basic, preclinical, and/or clinical research with a clear, achievable goal. Projects with little to no existing preliminary data but where hypothetical rationale is highly compelling and study results can make the case for continuing (or discontinuing) a line of research are encouraged.
CONTACT: Please see URL for contact information. For more information see https://www.michaeljfox.org/research/grant-detail.php?id=3
From The Foundation Center's Philanthropy News Digest RFP Bulletin e-mail, 5/31/13icon
Subject(s) mental health, medical research

Scleroderma Foundation Seeks Letters of Intent for Collaborative Research Projects
SOURCE: Scleroderma Foundation
APPLICATION DEADLINE: Letter of Intent: 9/2/13.
$ AVAILABLE: Grants of up to $500,000 for up to two years.
ELIGIBILITY: To be eligible, applicant organizations or educational institutions must be a designated Scleroderma Foundation Center. To be designated as a Scleroderma Foundation Center, organizations or educational institutions must demonstrate expertise in scleroderma, including expertise in clinical and laboratory-based research; conduct educational activities and clinical trials related to scleroderma; provide information on advances in the care and treatment of patients with scleroderma to healthcare professionals and the public; and seek and attain approval as a Scleroderma Center from the medical advisory board of the Scleroderma Foundation.
PURPOSE: The Scleroderma Foundation is accepting Letters of Intent for collaborative projects that aim to advance significant research on scleroderma.
Grants will be awarded to support basic, translational, or clinical research projects between two or more Scleroderma Foundation Scleroderma Centers.
CONTACT: Please see URL for contact information. For more information see http://www.scleroderma.org/site/PageServer?pagename=prof_research_collaborative#.UZy2oze2WXM
From The Foundation Center's Philanthropy News Digest RFP Bulletin e-mail, 5/31/13icon
Subject(s) medical research


Events

Spectrum of Care: The Interface
SPONSOR: Texas Department of State Health Services (DSHS), Texas/Oklahoma AIDS Education & Training Center (TX/OK AETC)
WHEN: June 14, 8 am to 5 pm.
WHERE: Courtyard San Antonio - SeaWorld Westover Hills, 11605 State Highway 151, (San Antonio, TX).
DESCRIPTION: The Texas Department of State Health Services (DSHS) and the Texas/Oklahoma AIDS Education & Training Center (AETC) have partnered in creating a free, one-day continuing education (CE) event for clinical providers, such as physicians, nurses, and mental health providers around the treatment and management of co-morbid HIV-disease.
“Spectrum of Care: The Interface” is intended to assist in increasing treatment capacity across the state to meet the complex needs of HIV-positive individuals dealing with co-occurring mental illness and viral hepatitis conditions. This training will not only serve to increase the efficacy and quality of delivered services through the provision of up-to-date education and training for clinical providers, but will also address training needs for collateral partners (such as social workers, Registered Sanitarians, and Certified Health Education Specialists) who are involved in the provision of HIV services and/or the treatment planning of HIV patients.
COST: Free, but registration is required at http://aidseducation.org/SOC.php. Training groups will be limited to 125 registrants.
CONTACT: Call Martha Guerrero at (214) 590-2725.
From DSHS HIV/STD Program HIV-STD Insider e-mail, 6/6/13icon

HIV Integrated Care Training in Austin
SPONSOR: HIV Integrated Care
WHEN: July 29-30, 8:30 am to 4:30 pm.
WHERE: Austin State Hospital Campus, West Auditorium, 4110 Guadalupe, Building 631, (Austin, TX).
DESCRIPTION: The next HIV Integrated Care training is scheduled for June 29-30 in Austin. Mental health issues and substance use delays HIV testing and negatively affects HIV treatment adherence and treatment outcomes. It is less well known that HIV infection can also increase the risk for mental health conditions and substance use, thus making it even more difficult to engage and retain in care those most needing services.
HIV Integrated Care Trainings are offered to increase participants’ proficiency in developing sustainable partnerships with their HIV clients with co-occurring disorders in order to: more effectively link them to needed services; assist them in engaging in and staying in care; effectively motivate adherence to all of their treatment regimens; and assist program administrators in developing more user-friendly service systems that minimize stigma.
COST: Free, but registration is required at http://www.surveymonkey.com/s/37VD76Q.
CONTACT: Danielle N. Pope at e-mail: dpope@apa.org.
From DSHS HIV/STD Program HIV-STD Insider e-mail, 6/6/13icon


returnReturn to Alert

  • Loading...
Last updated June 17, 2014